Fertility startup Inito wants to use AI-designed antibodies to expand at-home health tests
Short excerpt below. Click through to read at the original source.
Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.